Compounds > 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone
Page last updated: 2024-09-03

3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone and transforming growth factor beta

3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone has been researched along with transforming growth factor beta in 1 studies

Compound Research Comparison

Studies
(3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone)		Trials
(3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone)		Recent Studies (post-2010)
(3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone)		Studies
(transforming growth factor beta)		Trials
(transforming growth factor beta)		Recent Studies (post-2010) (transforming growth factor beta)
250249,11956017,610

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taketo, MM1

Reviews

1 review(s) available for 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone and transforming growth factor beta

ArticleYear
[Intestinal polyposis in APC knockout mice: mechanism of tumorigenesis and chemotherapy].
    Seikagaku. The Journal of Japanese Biochemical Society, 1999, Volume: 71, Issue:11

    Topics: Adenomatous Polyposis Coli; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; DNA-Binding Proteins; Furans; Heterozygote; Isoenzymes; Loss of Heterozygosity; Mice; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; Signal Transduction; Trans-Activators; Transforming Growth Factor beta

1999